These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9315987)

  • 21. Predicting response to fluoxetine in geriatric patients with major depression.
    Koran LM; Hamilton SH; Hertzman M; Meyers BS; Halaris AE; Tollefson GD; Downs JM; Folks DG; Jeste DV; Lazarus LW
    J Clin Psychopharmacol; 1995 Dec; 15(6):421-7. PubMed ID: 8748431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study.
    Heiligenstein JH; Hoog SL; Wagner KD; Findling RL; Galil N; Kaplan S; Busner J; Nilsson ME; Brown EB; Jacobson JG
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):207-17. PubMed ID: 16553541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
    Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
    Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC; DelBello MP; Landry J; Usher RW
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Problem-solving ability and comorbid personality disorders in depressed outpatients.
    Harley R; Petersen T; Scalia M; Papakostas GI; Farabaugh A; Fava M
    Depress Anxiety; 2006; 23(8):496-501. PubMed ID: 16845662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.
    Strik JJ; Honig A; Lousberg R; Lousberg AH; Cheriex EC; Tuynman-Qua HG; Kuijpers PM; Wellens HJ; Van Praag HM
    Psychosom Med; 2000; 62(6):783-9. PubMed ID: 11138997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine treatment for weight reduction in steroid-induced obesity: a pilot study in myasthenia gravis patients.
    Achiron A; Barak Y; Noy S; Pinhas-Hamiel O
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):111-3. PubMed ID: 10082236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
    Iovieno N; van Nieuwenhuizen A; Clain A; Baer L; Nierenberg AA
    Depress Anxiety; 2011 Feb; 28(2):137-44. PubMed ID: 21284066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.
    Heiligenstein JH; Tollefson GD; Faries DE
    J Affect Disord; 1994 Mar; 30(3):163-73. PubMed ID: 8006243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
    Silverstone PH; Ravindran A
    J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study.
    Gelenberg AJ; Dunner DL; Rothschild AJ; Pedersen R; Dorries KM; Ninan PT
    J Nerv Ment Dis; 2013 Apr; 201(4):266-73. PubMed ID: 23538970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
    Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
    Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents.
    Nilsson M; Joliat MJ; Miner CM; Brown EB; Heiligenstein JH
    J Child Adolesc Psychopharmacol; 2004; 14(3):412-7. PubMed ID: 15650497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine: a randomized clinical trial in the treatment of obesity.
    Goldstein DJ; Rampey AH; Enas GG; Potvin JH; Fludzinski LA; Levine LR
    Int J Obes Relat Metab Disord; 1994 Mar; 18(3):129-35. PubMed ID: 8186809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study.
    Martenyi F; Brown EB; Caldwell CD
    J Clin Psychopharmacol; 2007 Apr; 27(2):166-70. PubMed ID: 17414240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group.
    Schneider LS; Small GW; Hamilton SH; Bystritsky A; Nemeroff CB; Meyers BS
    Am J Geriatr Psychiatry; 1997; 5(2):97-106. PubMed ID: 9106373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.